Origin Bio specializes in developing AI technology aimed at enhancing the safety of cell therapies. Their main product is the Axis multifunctional DNA model, which integrates generative design and functional prediction of regulatory DNA.
Key features of the Axis model include:
- Enhanced Predictive Capability: It outperforms Google DeepMind’s AlphaGenome in predicting regulatory element activity by an average of 6.7%.
- Unified Functionality: The model can generate regulatory DNA elements and predict their functions, combining capabilities that were previously separate.
- High-Affinity Prompts: It can drive up to 9 times enrichment of targeted transcription factor motifs compared to low-affinity prompts.
- Safety and Effectiveness: The multifunctional design aims to improve the safety and effectiveness of gene therapies through better control of gene expression.
These features make the Axis model a valuable tool for biotechnology researchers and genetic engineers focused on developing advanced cell therapies.
